RISK WARNING: Your capital is at risk. The risks include: the lack of liquidity in this market in terms of being able to realise investments and the loss of the value of investment. When you invest any loss in value will not be covered by the Financial Services Compensation Scheme.
Please read FULL risk warning.

Welcome to Envestors Channel Islands

Stay close to Opportunity

  • Target

    £400,000

  • Type

    Equity

  • Close Date

    Sep 7 2019

  • Status

    Open

Silver Swift Drinks

Silver Swift create award-winning 'better for you' premixed alcoholic drinks made using top British spirits, with a strong health focus in mind.

  • Sector: Restaurant / Catering / Food
  • Region: UK: South-West
  • Stage: Early stage - early revenues, pre-profit
  • Eligible Tax: EIS
  • Board Requirement: Will consider further board appointments
  • Pre Money Valuation: £1,500,000
  • Share Price: £11.70
  • Originator: Envestors
Total Pledged: £90,000
Max

£400,000

  • Target

    £1,000,000

  • Type

    Equity

  • Close Date

    Jul 8 2019

  • Status

    Open

DMD

DMD is building a global, digital content distribution enterprise delivering its world cinema service on-demand to 17m homes in Latin America.

  • Sector: Media and Creative
  • Region: UK: London
  • Stage: Established - existing revenue, pre-profit
  • Eligible Tax: EIS
  • Board Requirement: Will consider further board appointments
  • Pre Money Valuation: £2,925,000
  • Share Price: £5.00
  • Originator: Envestors
Total Pledged: £35,000
Max

£1,000,000

  • Target

    £3,000,000

  • Type

    Equity

  • Close Date

    Aug 30 2019

  • Status

    Open

Nova Pangaea Technologies

Nova Pangaea Technologies (NPT) has developed a technology for replacing fossil fuel with biomass waste using only heat and steam.

  • Sector: Environmental / Green
  • Region: UK: London
  • Stage: Early stage - early revenues, pre-profit
  • Eligible Tax: EIS
  • Board Requirement: Will consider further board appointments
  • Pre Money Valuation: £6,500,000
  • Share Price: £14.33
  • Originator: Envestors
Total Pledged: £756,700
Max

£3,000,000

  • Target

    £5,000,000

  • Type

    Equity

  • Close Date

    Jul 31 2019

  • Status

    Open

Cambridge Medical Technologies Limited

CMT has developed a lab-on-a-chip on a Band-Aid that continuously and imperceptibly monitors certain blood biomarkers present in intercellular fluid j

  • Sector: Healthcare
  • Region: UK: South-East
  • Stage: Early stage - early revenues, pre-profit
  • Eligible Tax: EIS
  • Board Requirement: Will consider further board appointments
  • Pre Money Valuation: £25,000,000
  • Share Price: £82.50
  • Originator: Envestors
Total Pledged: £1,775,158
Max

£5,000,000

We are proud to be working with: